Inclusion criteria | Exclusion criteria |
---|---|
• Adult patients (NEXT) | • Chronic myeloid leukaemia |
• Adult and paediatric patients (VENICE) | • Myelodysplastic syndrome |
• Solid tumours or haematological malignancies | • Hypersensitivity to the active substance |
• Treated or planned treatment with cytotoxic chemotherapy irrespective of cycle | • Hypersensitivity to one of the excipients of Nivestim™ |
• Indicated for G-CSF therapy according to the product label for Nivestim™ | • Undergoing treatment with G-CSF for ongoing FN (curative) (VENICE only)* |